Yasmin and Interstitial lung disease - a phase IV clinical study of FDA data

Summary:

Interstitial lung disease is reported as a side effect among people who take Yasmin (drospirenone; ethinyl estradiol), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Yaz, and have Metastatic renal cell carcinoma.

The phase IV clinical study analyzes which people have Interstitial lung disease when taking Yasmin. It is created by eHealthMe based on reports of 47,831 people who have side effects when taking Yasmin from the FDA, and is updated regularly.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,500 drugs and 1,839 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

On Jul, 12, 2026

47,831 people reported to have side effects when taking Yasmin.
Among them, 15 people (0.03%) have Interstitial lung disease.

Could Yasmin cause Interstitial lung disease?

Among these 15 people:

How long have people been on Yasmin when they have Interstitial lung disease? *

What is the gender of people who have Interstitial lung disease when taking Yasmin? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Interstitial lung disease when taking Yasmin? *

What are other drugs people take besides Yasmin? *

Yaz: 9 people, 60.00%
Afinitor: 4 people, 26.67%
Sunitinib Malate: 3 people, 20.00%
Morphine: 2 people, 13.33%
Adalat: 2 people, 13.33%
Xanax: 2 people, 13.33%
Lasix: 2 people, 13.33%
Paxil: 2 people, 13.33%
Drospirenone And Ethinyl Estradiol: 2 people, 13.33%
Cephalexin: 2 people, 13.33%

What are other side effects people have besides Interstitial lung disease? *

Pain: 9 people, 60.00%
Injury: 8 people, 53.33%
Emotional Distress: 6 people, 40.00%
Stress And Anxiety: 4 people, 26.67%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 26.67%
Gallbladder Disorder: 3 people, 20.00%
Gallstones (stone formation by bile component): 3 people, 20.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 20.00%
Cholecystitis Chronic (long lasting infection of gallbladder): 3 people, 20.00%
Cholecystitis Acute (rapid infection of gallbladder): 3 people, 20.00%

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 4 people, 26.67%
Pain: 3 people, 20.00%
Pneumonia: 2 people, 13.33%
Heavy Or Prolong Menstrual Bleeding: 2 people, 13.33%
Menstruation Irregular: 1 person, 6.67%
Acne (skin problems that cause pimples): 1 person, 6.67%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 6.67%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 6.67%
Colon Cancer: 1 person, 6.67%
Colon Cancer Recurrent: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and have Interstitial lung disease?

- Check whether Interstitial lung disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Yasmin:

Yasmin (48,855 reports)

Interstitial lung disease treatments and more:

Interstitial lung disease (69,102 reports)

How severe was Interstitial lung disease and when was it recovered:

Interstitial lung disease in Yasmin

Expand to all the drugs that have ingredients of drospirenone; ethinyl estradiol:

Interstitial lung disease and drugs with ingredients of drospirenone; ethinyl estradiol

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol (the active ingredients of Yasmin) and Yasmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.